Alnylam Pharmaceuticals


Alnylam Pharmaceuticals Stock Quote
$69.37 $1.46 0.0%
BATS BZX Real Time Price as of May 24, 2019, 3:36 p.m. View Interactive ALNY Charts

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes.

News & Analysis: Alnylam Pharmaceuticals

The Fool has written over 200 articles on Alnylam Pharmaceuticals.


Market Moves



2 Biotechs With Big Dates in April

Here's what you need to know about two biotechs that will present trial results that could send their stock prices soaring -- or plummeting.

RNAi Goes Big-Time in 2018

A first-in-kind FDA approval catapulted this treatment approach into the spotlight.

Interactive Chart